Cargando…
Regulation of Suppressors of Cytokine Signaling as a Therapeutic Approach in Autoimmune Diseases, with an Emphasis on Multiple Sclerosis
Multiple sclerosis (MS) is an inflammatory demyelinating, presumably autoimmune disease of the central nervous system (CNS). Among the available MS therapies, interferon (IFN)β and the recently introduced statins have been reported to exert their immunomodulatory effects through the induction of SOC...
Autores principales: | Ramgolam, Vinod S., Markovic-Plese, Silva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206360/ https://www.ncbi.nlm.nih.gov/pubmed/22132325 http://dx.doi.org/10.1155/2011/635721 |
Ejemplares similares
-
T Cell LFA-1 Engagement Induces HuR-Dependent Cytokine mRNA Stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 Signaling Cascade
por: Ramgolam, Vinod S., et al.
Publicado: (2010) -
IL-11 in multiple sclerosis
por: Zhang, Xin, et al.
Publicado: (2015) -
Activated IL-1RI Signaling Pathway Induces Th17 Cell Differentiation via Interferon Regulatory Factor 4 Signaling in Patients with Relapsing-Remitting Multiple Sclerosis
por: Sha, Yonggang, et al.
Publicado: (2016) -
Dalfampridine for Mobility Limitations in People With Multiple Sclerosis May Be Augmented by Physical Therapy: A Non-randomized Two-Group Proof-of-Concept Pilot Study
por: Plummer, Prudence, et al.
Publicado: (2022) -
Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications
por: Palle, Pushpalatha, et al.
Publicado: (2017)